Obesity Adversely Affects Serum Anti-müllerian Hormone (AMH) Levels in Caucasian Women

Overview

Journal J Assist Reprod Genet

Publisher Springer

Specialties Genetics
Reproductive Medicine

Date 2015 Jul 22

PMID 26194744

Citations 35

Authors

Vicky Moy

Sangita Jindal

Harry Lieman

Erkan Buyuk

Affiliations

Soon will be listed here.

Abstract

Objective: Previous studies regarding the effect of obesity on serum anti-müllerian hormone (AMH) levels have been conflicting. Our aim was to determine the effect of obesity on serum AMH levels among women from different racial backgrounds.

Methods: The medical records of 350 women (159 Caucasian, 99 African-American, 58 Hispanic, 34 Asian with ages 16-46) evaluated for infertility at an academic-affiliated center and who had AMH levels measured as part of their evaluation were reviewed. Age, AMH, body mass index (BMI), self-reported race, etiology of infertility, smoking history, maximum serum early follicular follicle-stimulating hormone (FSH) levels, antral follicle count (AFC), and history of ovarian surgery, chemotherapy, or radiotherapy were recorded.

Results: Age correlated negatively with AMH and antral follicle count across all races (p < 0.05). After adjusting for age, polycystic ovary syndrome diagnosis, and smoking, elevated BMI had a negative correlation with AMH in Caucasian women (β = 0.17, p = 0.01) but not in African-American, Hispanic, or Asian women.

Conclusion: Elevated BMI correlates negatively with AMH in Caucasian women but not in African-American, Hispanic, or Asian women. Additional studies are needed to elucidate further the effect of race on the interaction between obesity and ovarian reserve.

Citing Articles

Impact of psychological stress on ovarian function: Insights, mechanisms and intervention strategies (Review).

Hu Y, Wang W, Ma W, Wang W, Ren W, Wang S Int J Mol Med. 2024; 55(2).

PMID: 39704226 PMC: 11670866. DOI: 10.3892/ijmm.2024.5475.

AMH in Males: Effects of Body Size and Composition on Serum AMH Levels.

Tandl V, Haudum C, Eberhard K, Hutz B, Foessl I, Kolesnik E J Clin Med. 2023; 12(13).

PMID: 37445513 PMC: 10342968. DOI: 10.3390/jcm12134478.

Assessment of Nutritional Status and Its Influence on Ovarian Reserve: A Systematic Review.

Prieto-Huecas L, Piera-Jordan C, De la Cruz-Delgado V, Zaragoza-Marti A, Garcia-Velert M, Tordera-Terrades C Nutrients. 2023; 15(10).

PMID: 37242163 PMC: 10224518. DOI: 10.3390/nu15102280.

Neighborhood disadvantage is associated with decreased ovarian reserve in women with overweight and obesity.

Komorowski A, Walter J, Martin C, Bedrick B, Riley J, Jungheim E Fertil Steril. 2022; 119(4):653-660.

PMID: 36565977 PMC: 10079614. DOI: 10.1016/j.fertnstert.2022.12.026.

Effect of Reproductive and Lifestyle Factors on Anti-Mullerian Hormone Levels in Women of Indian Origin.

Banerjee K, Thind A, Bhatnagar N, Singla B, Agria K, Bajaj P J Hum Reprod Sci. 2022; 15(3):259-271.

PMID: 36341011 PMC: 9635372. DOI: 10.4103/jhrs.jhrs_79_22.

References

Piouka A, Farmakiotis D, Katsikis I, Macut D, Gerou S, Panidis D . Anti-Mullerian hormone levels reflect severity of PCOS but are negatively influenced by obesity: relationship with increased luteinizing hormone levels. Am J Physiol Endocrinol Metab. 2008; 296(2):E238-43. DOI: 10.1152/ajpendo.90684.2008. View

Marshall N, Spong C . Obesity, pregnancy complications, and birth outcomes. Semin Reprod Med. 2012; 30(6):465-71. DOI: 10.1055/s-0032-1328874. View

Seifer D, Golub E, Lambert-Messerlian G, Benning L, Anastos K, Watts D . Variations in serum müllerian inhibiting substance between white, black, and Hispanic women. Fertil Steril. 2008; 92(5):1674-8. PMC: 3037722. DOI: 10.1016/j.fertnstert.2008.08.110. View

Butts S, Seifer D . Racial and ethnic differences in reproductive potential across the life cycle. Fertil Steril. 2009; 93(3):681-90. DOI: 10.1016/j.fertnstert.2009.10.047. View

Halawaty S, Elkattan E, Azab H, ElGhamry N, Al-Inany H . Effect of obesity on parameters of ovarian reserve in premenopausal women. J Obstet Gynaecol Can. 2010; 32(7):687-90. DOI: 10.1016/s1701-2163(16)34573-x. View

Cassar S, Teede H, Moran L, Joham A, Harrison C, Strauss B . Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins. Clin Endocrinol (Oxf). 2014; 81(6):899-906. DOI: 10.1111/cen.12557. View

Scheffer G, Broekmans F, Dorland M, Habbema J, Looman C, Te Velde E . Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility. Fertil Steril. 1999; 72(5):845-51. DOI: 10.1016/s0015-0282(99)00396-9. View

Levi A, Raynault M, Bergh P, Drews M, Miller B, Scott Jr R . Reproductive outcome in patients with diminished ovarian reserve. Fertil Steril. 2001; 76(4):666-9. DOI: 10.1016/s0015-0282(01)02017-9. View

Rich-Edwards J, Spiegelman D, Garland M, Hertzmark E, Hunter D, Colditz G . Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology. 2002; 13(2):184-90. DOI: 10.1097/00001648-200203000-00013. View

10.

. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004; 81(1):19-25. DOI: 10.1016/j.fertnstert.2003.10.004. View

11.

van Rooij I, Broekmans F, Scheffer G, Looman C, Habbema J, de Jong F . Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril. 2005; 83(4):979-87. DOI: 10.1016/j.fertnstert.2004.11.029. View

12.

Freeman E, Gracia C, Sammel M, Lin H, Lim L, Strauss 3rd J . Association of anti-mullerian hormone levels with obesity in late reproductive-age women. Fertil Steril. 2006; 87(1):101-6. DOI: 10.1016/j.fertnstert.2006.05.074. View

13.

Gesink Law D, MacLehose R, Longnecker M . Obesity and time to pregnancy. Hum Reprod. 2006; 22(2):414-20. PMC: 1924918. DOI: 10.1093/humrep/del400. View

14.

Maheshwari A, Stofberg L, Bhattacharya S . Effect of overweight and obesity on assisted reproductive technology--a systematic review. Hum Reprod Update. 2007; 13(5):433-44. DOI: 10.1093/humupd/dmm017. View

15.

Seifer D, MacLaughlin D . Mullerian Inhibiting Substance is an ovarian growth factor of emerging clinical significance. Fertil Steril. 2007; 88(3):539-46. DOI: 10.1016/j.fertnstert.2007.02.014. View

16.

Pasquali R, Patton L, Gambineri A . Obesity and infertility. Curr Opin Endocrinol Diabetes Obes. 2007; 14(6):482-7. DOI: 10.1097/MED.0b013e3282f1d6cb. View

17.

van der Steeg J, Steures P, Eijkemans M, Habbema J, Hompes P, Burggraaff J . Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2007; 23(2):324-8. DOI: 10.1093/humrep/dem371. View

18.

Riggs R, Duran E, Baker M, Kimble T, Hobeika E, Yin L . Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age. Am J Obstet Gynecol. 2008; 199(2):202.e1-8. DOI: 10.1016/j.ajog.2008.05.004. View

19.

Epplein M, Reed S, Voigt L, Newton K, Holt V, Weiss N . Risk of complex and atypical endometrial hyperplasia in relation to anthropometric measures and reproductive history. Am J Epidemiol. 2008; 168(6):563-70. PMC: 2727194. DOI: 10.1093/aje/kwn168. View

20.

Azrad M, Gower B, Hunter G, Nagy T . Racial differences in adiponectin and leptin in healthy premenopausal women. Endocrine. 2012; 43(3):586-92. PMC: 3541432. DOI: 10.1007/s12020-012-9797-6. View